Anti-tumour activity of T cells expressing chimeric receptors which incorporate both primary and costimulatory signalling sequences

被引：0
|
作者：
Lawson, ADG [1 ]
Finney, HM [1 ]
Moser, RN [1 ]
Bergin, M [1 ]
Suitters, A [1 ]
Antoniw, P [1 ]
Eddleston, A [1 ]
Weir, ANC [1 ]
机构：
[1] Celltech R&D Ltd, Slough SL1 4EN, Berks, England
来源：
CANCER GENE THERAPY | 2001年 / 8卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
PD46
引用
收藏
页码：922 / 922
页数：1
相关论文
共 50 条
  • [41] Clinical anti-lymphoma activity and toxicity of T cells expressing a novel anti-CD19 chimeric antigen receptor with fully-human variable regions.
    Brudno, Jennifer N.
    Hartman, Steven D.
    Pittaluga, Stefania
    Stroncek, David
    Lam, Norris
    Kanakry, Jennifer Ann
    Pavletic, Steven Zivko
    Mikkilineni, Lekha
    Bagheri, Mohammadhadi
    Roschewski, Mark J.
    Dean, Robert M.
    Rose, Jeremy J.
    Patel, Rashmika
    Hansen, Brenna G.
    Gress, Ronald
    Kochenderfer, James
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Anti-tumour activity of heat-shock protein 60-recognizing CD4+ T cells against syngeneic murine renal cell carcinoma
    Eto, M
    Harada, M
    Tatsugami, K
    Harano, M
    Koga, H
    Matsuzaki, G
    Naito, S
    BJU INTERNATIONAL, 2005, 95 (03) : 420 - 423
  • [43] ENHANCED EXPRESSION AND ANTI-TUMOUR ACTIVITY OF T CELLS ENGINEERED TO EXPRESS A CYSTEINE-MODIFIED TCR TARGETING A FRAMESHIFT MUTATION IN MSI-HI COLORECTAL CANCER
    Inderberg-Suso, E.
    Walchli, S.
    Myhre, M. R.
    Wang, M.
    Almasbak, H.
    Kvalheim, G.
    Gaudemack, G.
    CYTOTHERAPY, 2014, 16 (04) : S27 - S28
  • [44] Human invariant Vα24+ natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells
    Nicol, A
    Nieda, M
    Koezuka, Y
    Porcelli, S
    Suzuki, K
    Tadokoro, K
    Durrant, S
    Juji, T
    IMMUNOLOGY, 2000, 99 (02) : 229 - 234
  • [45] Human leucocyte antigen class I-redirected anti-tumour CD4+ T cells require a higher T cell receptor binding affinity for optimal activity than CD8+ T cells
    Tan, M. P.
    Dolton, G. M.
    Gerry, A. B.
    Brewer, J. E.
    Bennett, A. D.
    Pumphrey, N. J.
    Jakobsen, B. K.
    Sewell, A. K.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2017, 187 (01): : 124 - 137
  • [46] Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma
    Graham, Charlotte Elizabeth
    Jozwik, Agnieszka
    Quartey-Papafio, Ruby
    Ioannou, Nikolaos
    Metelo, Ana M.
    Scala, Carlo
    Dickson, Glenda
    Stewart, Orla
    Almena-Carrasco, Maria
    Peranzoni, Elisa
    Ramsay, Alan G.
    Patten, Piers E. M.
    Pertel, Thomas
    Farzaneh, Farzin
    Dupouy, Sandra
    Pepper, Andrea
    Benjamin, Reuben
    LEUKEMIA, 2021, 35 (12) : 3581 - 3584
  • [47] Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma
    Charlotte Elizabeth Graham
    Agnieszka Jozwik
    Ruby Quartey-Papafio
    Nikolaos Ioannou
    Ana M. Metelo
    Carlo Scala
    Glenda Dickson
    Orla Stewart
    Maria Almena-Carrasco
    Elisa Peranzoni
    Alan G. Ramsay
    Piers E. M. Patten
    Thomas Pertel
    Farzin Farzaneh
    Sandra Dupouy
    Andrea Pepper
    Reuben Benjamin
    Leukemia, 2021, 35 : 3581 - 3584
  • [48] NG-348: a novel oncolytic virus designed to mediate anti-tumour activity via the potent and selective polyclonal activation of tumor-infiltrating T-cells
    Champion, Brian R.
    Besneux, Matthieu
    Marino, Nalini
    Plumb, Darren
    Kodialbail, Prithvi
    Illingworth, Sam
    Lear, Rochelle
    Brown, Alice C.
    CANCER RESEARCH, 2017, 77
  • [49] In vivo anti-tumor activity of murine hematopoietic stem cells expressing a p185HER2-specific chimeric T-cell receptor gene
    MICHAEL S FRIEDMAN
    MARIANNE T HUBEN
    JENNIFER FULLER
    ALFRED E CHANG
    JAMES J MULE
    KEVIN T MCDONAGH
    Journal of Microbiology and Immunology, 2006, (02) : 117 - 124
  • [50] The absolute number as well as the activation kinetics of regulatory T-cells determines the successful generation of primary anti-tumour and pathogen-specific immune responses from the naive donor T-cell repertoire
    Jedema, I.
    Pots, J.
    van de Meent, M.
    Willemze, R.
    Falkenburg, J. H. F.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S52 - S53
12345